Loading...
Email Alert | RSS

Table of Content

    10 July 2024, Volume 46 Issue 7
    Special Topic
    New challenges in tuberculosis control: startling new findings on aerosol detection
    Li Meng, Gao Qian
    Chinese Journal of Antituberculosis. 2024, 46(7):  739-742.  doi:10.19982/j.issn.1000-6621.20240153
    Abstract ( 239 )   HTML ( 27 )   PDF (1007KB) ( 181 )   Save
    References | Related Articles | Metrics

    Aerosols are vectors of Mycobacterium tuberculosis transmission. Are the characteristics of Mycobacterium tuberculosis in aerosols the same as those in sputum? A recent paper in the Proceedings of the National Academy of Sciences of the United States of America presents startling findings on Mycobacterium tuberculosis in aerosols. This research may pose new challenges for tuberculosis control. In this paper, we will briefly introduce this study and present some thoughts based on this research.

    Service analysis about transformation of scientific and technological achievements in diagnosis of tuberculosis in vitro
    Zhang Hongjing, Chu Hongqian, Sun Zhaogang, Xie Zhongyao
    Chinese Journal of Antituberculosis. 2024, 46(7):  743-749.  doi:10.19982/j.issn.1000-6621.20240048
    Abstract ( 179 )   HTML ( 11 )   PDF (2625KB) ( 405 )   Save
    Figures and Tables | References | Related Articles | Metrics

    A definitive diagnosis is paramount for effective tuberculosis (TB) prevention and treatment. Early and accurate diagnosis is crucial for timely treatment of TB patients, while advancements in diagnostic technologies are essential for effectively identifying patients. The In Vitro diagnostic (IVD) products for TB boasts a vast market and strong clinical demand. However, current challenges persist. Basic research and development often fall short of meeting clinical needs, and the pool of diagnostic-related patent technical achievements remains limited. Ongoing technical breakthroughs are essential to address these gaps. Existing diagnostic products often lack the versatility to meet the full spectrum of clinical needs. To drive rapid growth in the TB IVD industry and bolster prevention and control efforts, comprehensive service offerings are required across the entire technology development lifecycle—from achievement to productization and commercialization.

    Original Article
    Analysis of risk factors for viral pneumonia combined with invasive pulmonary mycosis
    Chai Dongyu, Qin Shuyi, Zhang Ronghua, Zou Nannan, Wang Xin
    Chinese Journal of Antituberculosis. 2024, 46(7):  750-755.  doi:10.19982/j.issn.1000-6621.20240145
    Abstract ( 207 )   HTML ( 16 )   PDF (760KB) ( 134 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To explore the related risk factors for the development of viral pneumonia combined with invasive pulmonary mycosis (IPM). Methods: Using a retrospective study method, 105 patients diagnosed with viral pneumonia combined with IPM who were hospitalized at the Affiliated Central Hospital of Shandong First Medical University from January 2021 to October 2023 were selected as the observation group; meanwhile, 105 patients with viral pneumonia who did not have IPM during the same period were selected as the control group in a 1∶1 ratio. The sociodemographic characteristics, clinical manifestations, imaging findings, and laboratory test results of the two groups were collected and analyzed. Logistic regression was used to analyze the influencing factors of IPM in patients with viral pneumonia. Results: In the observation group, 51.4% (54/105), 25.7% (27/105), 43.8% (46/105), 36.2% (38/105) and 23.8% (25/105) of the patients had diabetes, a history of malignant tumor, pleural effusion, bacterial infection, and a positive serum G test, respectively; In the control group, the corresponding figures were 35.2% (37/105), 6.7% (7/105), 19.0% (20/105), 13.3% (14/105), and 2.9% (3/105) respectively, and the differences were statistically significant (χ2=5.604, P=0.018; χ2=14.037, P<0.001; χ2=14.937, P<0.001; χ2=14.722, P<0.001; χ2=19.945, P<0.001). Multivariate logistic regression analysis showed that diabetes (OR(95%CI): 2.452 (1.164-5.163)), history of malignancy (OR(95%CI): 11.688 (3.707-36.847)), pleural effusion (OR(95%CI): 2.484 (1.123-5.494)), bacterial infection (OR(95%CI): 3.341 (1.410-7.920)), and positive serum G test (OR(95%CI): 13.649 (3.267-57.029)) were independent risk factors for the occurrence of IPM in patients with viral pneumonia. Conclusion: For patients diagnosed with viral pneumonia, attention should be paid to the risk of IPM in those with diabetes, a history of malignant tumor, pleural effusion, bacterial infection and a positive serum G test.

    Clinicopathologic characteristics of 34 cases non-tuberculous mycobacterial disease
    Zhang Hui, Ge Li, Zhang Yuhan, Feng Ruie
    Chinese Journal of Antituberculosis. 2024, 46(7):  756-762.  doi:10.19982/j.issn.1000-6621.20240151
    Abstract ( 209 )   HTML ( 15 )   PDF (2390KB) ( 204 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To explore the clinicopathological characteristics of non-tuberculous mycobacterial (NTM) disease. Methods: Clinical and pathological data from 34 NTM patients who were diagnosed and treated in Peking Union Medical College Hospital between March 1, 2015 and December 31, 2023 were retrospectively collected. All patients were divided into disseminated NTM disease group (14 cases) and non-disseminated NTM disease group (20 cases). The clinicopathological characteristics of these groups were analyzed and compared. Results: Twenty-two patients (64.71%, 22/34) were infected with Mycobacterium avium/intracellular; 6 patients (17.65%, 6/34) were caused by Turtle/Mycobacterium abscessus infection, and 4 patients (11.76%, 4/34) were infected with Mycobacterium kansasii. Histopathological examination revealed granulomatous lesions in 23 cases (67.65%, 23/34). Of these, 19 cases (82.61%, 19/23) exhibited loosely arranged granuloma, 7 cases (30.43%, 7/23) showed suppurative granulomas, and basophilic necrosis was found in 5 cases (14.71%, 5/34). Pink-stained caseous necrosis was reviewed in 4 cases (11.76%, 4/34), and multinucleated giant cell reaction was observed in 18 cases (52.94%, 18/34). Positive acid-fast staining was identified in 5 out of 21 cases examined (23.81%, 5/21). Conclusion: The pathological features of NTM disease are diverse, with loosely arranged epithelioid granulomas being the most common finding. These granulomas are often accompanied by multinucleated giant cell reactions and suppurative granuloma.

    A case report and literature review of Mycobacterium asiaticum pulmonary disease
    He Xiangrong, Chen Hua, Chen Pinru, Liang Feng, Ren Huili, Zhu Jialou, Hu Jinxing, Tan Yaoju
    Chinese Journal of Antituberculosis. 2024, 46(7):  763-769.  doi:10.19982/j.issn.1000-6621.20240147
    Abstract ( 212 )   HTML ( 19 )   PDF (2305KB) ( 211 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To report the clinical diagnosis and treatment of a patient with Mycobacterium asiaticum pulmonary disease, and to analyze the clinical features, imaging characteristics, and prognosis of the disease in conjunction with a review of the literature. Methods: From January 1971 to September 2019, we searched, 27 relevant literatures were retrieved from PubMed database with “Mycobacterium asiaticum” as the searching term, of which only 7 cases were Mycobacterium asiaticum pulmonary disease cases. “Mycobacterium asiaticum, pulmonary disease” as the search term, no relevant literature was found in both Wanfang database and CNKI database. We summarized the characteristics of our patient and reviewed the literature of the selected cases. Results: Our patient with Mycobacterium asiaticum pulmonary disease was a middle-aged woman with structural pulmonary disease, with cough and sputum as the main complaints, bronchial dilatation and cavitation as the main image manifestations. Sputum and bronchoalveolar lavage fluid were positive for acid-fast staining and mycobacterial culture. DNA microarray chip method identified all as Mycobacterium tuberculosis complex, and they were resistant to rifampicin, isoniazid, levofloxacin, and bedaquiline. However, negative IGRA, and negative sputum/bronchoalveolar lavage fluid (BALF) TB-RNA and TB-DNA, and negative Mycobacterium tuberculosis molecular drug resistance detection (INH, RFP; probe melting curve method). BALF tNGS results suggested a clinical diagnosis of Mycobacterium asiaticum pulmonary disease. After treatment with anti-non-tuberculous mycobacterium drugs, the patient’s respiratory symptoms were relieved after 8 months of treatment, the lesion improved, and mycobacterial culture of sputum and BALF turned negative, indicating effective treatment. In the other 7 cases, there were 4 cases complicated with structural lung disease and 1 case complicated with tumor (no treatment was started). The lung lesions were mainly nodules and cavities formed, and there were differences in treatment plans. Finally, 3 cases achieved clinical cure after more than 1 year of treatment, 2 cases showed improvement in clinical symptoms and imaging (including 1 case achieved bacteriological negative conversion), and 1 case relapsed. Conclusion: Reports on Mycobacterium asiaticum pulmonary disease are scarce, and the clinical manifestations are atypical and easily misdiagnosed. In patients with positive acid-fast staining and mycobacterial culture and mycobacterial identification suggestive of the Mycobacterium tuberculosis complex but negative for TB-RNA and TB-DNA, it is important to consider non-tuberculous mycobacterial pulmonary disease. The tNGS test aids in clinical diagnosis and should be emphasized by clinicians.

    Clinical characteristics of 220 cases of pulmonary tuberculosis combined with chronic pulmonary aspergillosis
    Yang Chengqing, Chen Shufang, Mei Chunlin, Cao Tanze, Feng Wei, Liu Xiuping, Xu Wenjing, Du Ronghui
    Chinese Journal of Antituberculosis. 2024, 46(7):  770-777.  doi:10.19982/j.issn.1000-6621.20240129
    Abstract ( 195 )   HTML ( 29 )   PDF (802KB) ( 180 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To analyze the clinical characteristics of pulmonary tuberculosis combined with chronic pulmonary aspergillosis, in order to improve the diagnosis and treatment capabilities of clinical doctors in China. Methods: A retrospective study was conducted on 220 patients with pulmonary tuberculosis complicated with chronic pulmonary aspergillosis admitted to Wuhan Pulmonary Hospital in 2022. Clinical data of these patients such as patient gender, age, past medical history, symptoms, course of disease, imaging findings and classification, laboratory tests and pathological results, treatment, outcomes, and follow-up were collected and their clinical characteristics were analyzed for their clinical characteristics. Results: Among 220 patients, 21 (9.55%) were complicated with active pulmonary tuberculosis, and 199 (90.45%) had post tuberculosis pulmonary diseases, of which 139 (63.18%) were complicated with other basic diseases, 49 (22.27%) with chronic obstructive pulmonary disease and 44 (20.00%) with diabetes. The most common type was chronic cavitary pulmonary aspergillosis in 120 cases (54.55%). Clinical symptoms included 207 cases of cough (94.09%), 178 cases of sputum (80.91%), and 126 cases of hemoptysis (57.27%). Laboratory tests mainly showed 112 cases of anemia (50.91%), 102 cases of decreased albumin (46.36%), 151 cases of erythrocyte sedimentation rate (68.64%), and 117 cases of elevated hCRP (53.18%). Chest CT often showed involvement of 189 cases (85.91%) of the upper lung and 162 cases (73.64%) of the right lung. Common signs included pulmonary cavities in 192 cases (87.27%), intraluminal septa in 166 cases (75.45%), pleural hypertrophy in 166 cases (75.45%), air crescent sign in 147 cases (66.82%), pulmonary fibrosis in 129 cases (58.64%), and emphysema in 121 cases (55.00%). The sputum or bronchoalveolar lavage fluid aspergillus nucleic acid test, serum aspergillus IgG test, and bronchoalveolar lavage fluid galactomannan antigen test showed a high positive rate for the diagnosis of chronic pulmonary aspergillosis, with rates of 54.09% (119/220),68.18% (150/220),and 60.91% (134/220), respectively. 80.77% (126/156) of the rate of stable condition was higher in the antifungal treatment group than in the non-antifungal treatment group 40.35% (23/57),without antifungal treatment (χ2=32.447,P=0.001). A total of 45 patients (30.20%) experienced recurrence during a one-year follow-up, with a recurrence rate of 19.84% (25/126) in the antifungal treatment group, which was much lower than 89.96% (20/23) in the non antifungal treatment group (χ2=41.561,P=0.001). Conclusion: Pulmonary tuberculosis, especially post tuberculosis pulmonary diseases, is prone to comorbidity with chronic pulmonary aspergillosis. Recurrent coughing, sputum production, hemoptysis, and chest CT showing pulmonary cavities and pleural hypertrophy should raise suspicion of comorbidity with chronic pulmonary aspergillosis. It is recommended to conduct serum aspergillosis IgG test and/or bronchoalveolar lavage fluid galactomannan antigen test or aspergillosis nucleic acid test to promptly confirm the diagnosis. Full course antifungal treatment and surgical treatment are effective treatment methods for treating chronic pulmonary aspergillosis.

    Analysis of influencing factors of treatment outcomes of retreated multidrug-resistant/rifampicin-resistant pulmonary tuberculosis patients: a national multicenter retrospective cohort study
    Ye Zhiteng, Ren Fei, Wang Hua, Yang Ming, Chen Yu, Chen Xiaohong, Wang Yun, Fan Lin
    Chinese Journal of Antituberculosis. 2024, 46(7):  778-784.  doi:10.19982/j.issn.1000-6621.20240088
    Abstract ( 267 )   HTML ( 33 )   PDF (1112KB) ( 195 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To analyze the influencing factors of treatment outcomes of retreated multidrug/rifampicin-resistant pulmonary tuberculosis (MDR/RR-PTB) patients. Methods: A multicenter retrospective cohort study was conducted to include 2291 MDR/RR-PTB patients admitted to six provincial tuberculosis designated hospitals from January 1, 2018 to December 31, 2020. Treatment information of those patients was followed up, clinical characteristics were recorded. Univariable and multivariable logistic regression were used to analyze the influencing factors of treatment outcomes of retreated MDR/RR-PTB patients. Results: Cure rate of 2291 patients was 56.44% (1293/2291), completion rate was 16.28% (373/2291), thus treatment success rate was 72.72% (1666/2291). Treatment failure rate was 11.39% (261/2291), mortality rate was 1.44% (33/2291), and loss of follow-up rate was 14.45% (331/2291). The analysis showed that combined with diabetes (OR(95%CI)=1.739 (1.315-2.301)), combined with liver disease (OR(95%CI)=2.230 (1.213-4.099)) and pulmonary cavity (OR(95%CI)=1.531 (1.244-1.885)) were risk factors for treatment failure, while regimen containing bedaquiline (OR(95%CI)=0.163 (0.097-0.274)) and gender being female (OR(95%CI)=0.713 (0.571-0.890)) were protective factors. Conclusion: The classification and treatment regime of retreated MDR/RR-PTB patients are complicated, and treatment outcomes of different types of retreated patients differentiated. Adverse and favorable factors affecting treatment outcomes should be fully identified to perform individualized treatment on patients.

    Original Article
    Randomization analysis of metformin treatment and the onset of tuberculosis with two-sample Mendelian randomization
    Li Tingting, Wang Longzhi, Liu Huanqing
    Chinese Journal of Antituberculosis. 2024, 46(7):  785-791.  doi:10.19982/j.issn.1000-6621.20230446
    Abstract ( 173 )   HTML ( 9 )   PDF (1998KB) ( 117 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To explore the correlation between metformin treatment and the onset of tuberculosis (TB) by Mendelian randomization (MR). Methods: We searched the MR Base database (http://app.mrbase.org) using metformin treatment as the exposure variable and TB incidence as the outcome variable. A set of publicly available genome-wide association studies (GWAS) were used to summarize the data. Mendelian randomization causal association analysis was performed using inverse variance weighting (IVW), weighted median, and MR-Egger regression analysis on two samples (462933 cases of metformin treatment, including 11552 cases and 451381 controls; 212453 cases of TB, including 549 cases and 211904 controls). Cochran’s Q statistic and I2 statistic were used to evaluate heterogeneity among single-nucleotide polymorphisms (SNPs). The “leave-one-out-method” sensitivity analysis and funnel plot were used to verify the reliability of the results. Results: Forty independent SNPs significantly associated with metformin treatment at the genome-wide level were selected as instrumental variables from GWAS, and 168 independent SNPs significantly associated with TB were selected. Inverse variance-weighted analysis showed a significant positive correlation between metformin treatment and TB incidence (P=0.022). MR-Egger regression analysis found that directional pleiotropy was unlikely to affect the results (intercept=-0.043, P=0.394), there was no evidence of a direct correlation between metformin treatment and TB incidence (P=0.150). However, the weighted median method analysis supported a positive correlation between metformin treatment and TB incidence (P=0.010). No heterogeneity was found in the inverse variance-weighted and MR-Egger analyses (Q=46.890, I2=0.168, P=0.175; Q=45.990, I2=0.174, P=0.181), increasing the reliability of the Mendelian randomization analysis estimates. The “leave-one-out-method” sensitivity analysis found that the overall Mendelian randomization estimates were stable, with no significant bias, and the results were reliable. The funnel plot also did not show asymmetry, indicating no directional pleiotropy and supporting the robustness and reliability of the results. Conclusion: After heterogeneity and sensitivity testing, the Mendelian randomization results obtained through inverse variance weighting, weighted median, and MR-Egger regression analysis support a positive correlation between metformin treatment and TB onset.

    Analysis of influencing factors of the full course use of anti-tuberculosis fixed-dose combination
    Du Fangfang, Cheng Shiming, Wang Ni, Zhou Lin, Guo Meng, Guo Xiuhua
    Chinese Journal of Antituberculosis. 2024, 46(7):  792-798.  doi:10.19982/j.issn.1000-6621.20240172
    Abstract ( 189 )   HTML ( 21 )   PDF (907KB) ( 185 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To analyze the full course use of anti-tuberculosis fixed-dose combination (FDC) in designated tuberculosis hospitals in China and its influencing factors, so as to provide basis for standardized use of FDC. Methods: According to the typical sampling methods, we selected 5 provinces in the east, middle and west of China, one provincial and one prefecture designated tuberculosis hospital were determined in each province. Using a prospective survey method, patients diagnosed and registered with pulmonary tuberculosis from April to July 2021 who received FDC treatment were selected as the study subjects to analyze the full course use and influencing factors of FDC. Results: Among the 2559 registered patients treated with FDC, 1988 patients underwent full course treatment, accounting for 77.69% (1988/2559), while 571 patients stopped using FDC midway, accounting for 22.31% (571/2559), and most of them occurred during the intensive treatment period, accounting for 69.00% (394/571). The results of multivariate Cox regression analysis showed that general hospitals (HR=2.595, 95%CI: 1.753-3.843), provincial hospitals (HR=4.813, 95%CI: 3.347-6.923), patients aged ≥60 years old (HR=1.573, 95%CI: 1.245-1.988), unknown drug resistance status (HR=1.408, 95%CI: 1.189-1.667), and adverse reactions (HR=15.934, 95%CI: 13.248-19.165) were risk factors for discontinuation of FDC. Conclusion: Targeted FDC standardized diagnosis and treatment training should be provided to doctors in general hospitals and provincial hospitals. For patients seeking treatment at the aforementioned hospitals, especially elderly patients, health education and medication guidance should be carried out to strengthen the management during the intensive treatment period to improve the full course usage rate of FDC.

    Analysis of treatment outcomes and influencing factors in 144 elderly patients with rifampicin drug-resistant pulmonary tuberculosis
    Gao Lei, Liang Yaxue, Liu Shengsheng, Wang Hua
    Chinese Journal of Antituberculosis. 2024, 46(7):  799-807.  doi:10.19982/j.issn.1000-6621.20240096
    Abstract ( 202 )   HTML ( 22 )   PDF (789KB) ( 179 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To analyze the treatment outcomes and influencing factors of elderly rifampicin drug-resistant pulmonary tuberculosis patients. Methods: A retrospective study was conducted, and clinical data of 144 elderly rifampicin drug-resistant pulmonary tuberculosis patients treated at the Anhui Chest Hospital from September 2020 to September 2023 were collected according to inclusion criteria. Treatment outcomes and influencing factors of patients were analyzed. Results: Among the 144 elderly drug-resistant pulmonary tuberculosis patients, 65 cases (45.14%) had favorable treatment outcomes, including 51 cases (35.42%) cured and 14 cases (9.72%) completed treatment; 79 cases (54.86%) had unfavorable treatment outcomes, including 7 cases (4.86%) getting treatment failure, 57 cases (39.58%) lost to follow-up, and 15 (10.42%) deaths, of which 7 were due to tuberculosis. Multifactor logistic regression analysis showed that body mass index (BMI) ≥18.5 (OR=0.131, 95%CI: 0.040-0.429, P<0.001) and long-term supervision and management (OR=0.052, 95%CI: 0.013-0.204, P<0.001) were protective factors for favorable outcomes, while comorbid diabetes (OR=3.266, 95%CI: 1.074-9.936, P=0.037) and gastrointestinal adverse reactions (OR=8.976, 95%CI: 2.582-31.205, P<0.001) were risk factors for unfavorable outcomes. Conclusion: The cure rate of elderly rifampicin drug-resistant pulmonary tuberculosis in Anhui Province was low. Attention should be paid to elderly patients with comorbid diabetes, poor nutritional status, lack of long-term supervised medicine taking and management, and drug adverse reactions. Active control of blood sugar levels, management of adverse reactions, strengthening nutritional support and supervision management are necessary to further improve the cure rate.

    The value of three proteins in diagnosing Mycobacterium tuberculosis infection
    Zhang Muli, Sun Zhaogang, Cao Tingming, Xie Zhongyao
    Chinese Journal of Antituberculosis. 2024, 46(7):  808-814.  doi:10.19982/j.issn.1000-6621.20240120
    Abstract ( 184 )   HTML ( 7 )   PDF (789KB) ( 135 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To investigate the diagnostic efficacy of three proteins—Krüppel-like transcription factor 2 (KLF2), guanylate-binding protein 5 (GBP5), and dual specificity phosphatase 3 (DUSP3)—and their assorted combinations in the detection of Mycobacterium tuberculosis (MTB) infection. Methods: Between January and March 2023, patients from Beijing Chest Hospital, Capital Medical University, and individuals undergoing concurrent health examinations were enrolled as study participants. Based on established tuberculosis diagnostic criteria, participants were categorized into three groups: active tuberculosis (ATB) group, consisting of 145 cases; latent tuberculosis infection (LTBI) group, also comprising 145 cases; and a healthy control (HC) group, which included 200 cases. Enzyme-linked immunosorbent assay (ELISA) was employed to quantify the serum levels of KLF2, GBP5, and DUSP3 at 450 nm wavelength absorbance, with results reported as median (interquartile range). The diagnostic potential of each protein, individually and in combination, was analyzed for detecting MTB infection using subject working characteristic curves. Results: Serum levels of KLF2 in the HC group were 0.317 (0.198, 0.496), significantly higher than those in the ATB group at 0.234 (0.160, 0.297) and in the LTBI group at 0.224 (0.145, 0.320), demonstrating statistical significance (P<0.001). Similarly, GBP5 levels in the ATB group were 0.327 (0.259, 0.402), significantly higher than those in the LTBI group at 0.196 (0.150, 0.273) and in the HC group at 0.180 (0.125, 0.281), with statistical significance (P<0.001). The serum level of DUSP3 in the ATB group was 0.329 (0.223, 0.458), significantly exceeding those in the LTBI group at 0.213 (0.160, 0.248) and in the HC group at 0.196 (0.132, 0.297), with statistical significance (P<0.001). Furthermore, the diagnostic performance of the dual protein combination of GBP5 and DUSP3 in differentiating ATB from LTBI, with an area under the curve (AUC) of 0.800, was found to be superior to that of single proteins and their various combinations, such as KLF2 (AUC of 0.534), GBP5 (AUC of 0.761), and DUSP3 alone (AUC of 0.720). For the dual protein combination of GBP5 and DUSP3 in differentiating ATB from LTBI, the sensitivity at the maximum Youden index reached 73.79%, with a specificity of 75.86%. This combination demonstrated superior diagnostic efficacy (AUC of 0.800) compared to the individual proteins and their various combinations. When distinguishing ATB from HC, this dual protein combination also excelled, achieving an AUC of 0.781, with sensitivity at the maximum Youden index at 77.93% and specificity at 71.50%. This was more effective than the individual performances of KLF2 (AUC of 0.629), GBP5 (AUC of 0.740), and DUSP3 (AUC of 0.716), and their different combinations. However, the diagnostic efficacy of the three proteins and their combinations in distinguishing LTBI from HC was less effective, with all AUC values being below 0.700. Conclusion: The findings of this study indicate that there is potential for developing immunodiagnostic methods based on protein levels for detecting MTB infection. Utilizing combinations of proteins such as KLF2, GBP5, and DUSP3 could enhance diagnostic accuracy, offering a promising approach to improve the efficacy of TB diagnostics.

    Meta-analysis of the diagnostic value of oral swab for pulmonary tuberculosis
    Wu Jinfeng, Yang Zhen, Zhang Fuzhen, Yao Cong
    Chinese Journal of Antituberculosis. 2024, 46(7):  815-822.  doi:10.19982/j.issn.1000-6621.20240161
    Abstract ( 217 )   HTML ( 11 )   PDF (3324KB) ( 190 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To systematically assess the diagnostic utility of oral swab testing in identifying pulmonary tuberculosis through a comprehensive meta-analysis. Methods: We conducted a detailed search of several databases including PubMed, Embase, Web of Science, Cochrane Library, CNKI, Wanfang, VIP, and CBM, to gather relevant studies published until April 12, 2024, that investigate the use of oral swabs for detecting pulmonary tuberculosis. Literature search, screening, data extraction, and quality evaluation were independently executed by two researchers. We employed STATA 16.0 to compute the aggregated sensitivity, specificity, positive likelihood ratios, negative likelihood ratios, and diagnostic odds ratios for both overall and subgroup analyses. Publication bias was methodically evaluated using Deek’s funnel plot analysis. Results: We retrieved a total of 173 records, of which 15 studies met the predefined inclusion and exclusion criteria. Our meta-analysis revealed that the aggregate sensitivity of oral swabs for the diagnosis of pulmonary tuberculosis was 65.0% (95%CI: 54.0%-75.0%), while the overall specificity reached 96.0% (95%CI: 92.0%-98.0%). In subgroup analyses focusing on adult patients with pulmonary tuberculosis, oral swabs demonstrated a sensitivity of 73.0% (95%CI: 64.0%-80.0%) and a specificity of 95.0% (95%CI: 83.0%-98.0%).The sensitivity of tongue swabs in diagnosing pulmonary tuberculosis was 73.0% (95%CI: 63.0%-80.0%), surpassing that of cheek swabs, which registered a sensitivity of 52.0% (95%CI: 34.0%-70.0%). Conclusion: Oral swabs represent a viable alternative diagnostic tool for pulmonary tuberculosis. Notably, tongue swabs exhibit greater sensitivity compared to cheek swabs in detecting pulmonary tuberculosis cases.

    Review Articles
    Research progress on interstitial lung disease combined with Mycobacterium tuberculosis infection
    Fu Keyan, Zhu Bangzheng, Ye Jian
    Chinese Journal of Antituberculosis. 2024, 46(7):  823-829.  doi:10.19982/j.issn.1000-6621.20240171
    Abstract ( 207 )   HTML ( 11 )   PDF (782KB) ( 241 )   Save
    References | Related Articles | Metrics

    Interstitial lung disease (ILD) and pulmonary tuberculosis (TB) are two prevalent respiratory diseases that can significantly impact health. TB, caused by Mycobacterium tuberculosis, is an infectious disease imposing a severe disease burden globally. In contrast, ILD is a group of non-communicable lung diseases characterized by chronic inflammation and alveolar interstitial fibrosis, profoundly affecting patients’ quality of life and prognosis. The interstitial and fibrotic changes in the lungs can mask signs of infection, while Mycobacterium tuberculosis infection can further worsen the condition of ILD. Therefore, when TB and ILD coexist, their interaction complicates timely diagnosis and treatment, adversely affecting the disease prognosis and outcome. This review summarizes the research progress in the epidemiology, pathogenesis, diagnostic methods, high-risk factors, and treatment of ILD combined with Mycobacterium tuberculosis infection, aiming to provide references for clinical diagnosis and treatment.

    Progress in clinical diagnosis and treatment of pulmonary cryptococcosis
    Han Wenya, Zhou Yangyu, Wang Meifang, Xue Xinying
    Chinese Journal of Antituberculosis. 2024, 46(7):  830-838.  doi:10.19982/j.issn.1000-6621.20240150
    Abstract ( 271 )   HTML ( 11 )   PDF (2519KB) ( 296 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Pulmonary cryptococcosis is an invasive fungal disease caused by respiratory inhalation of cryptococci, which can happen in both immunocompromised and immunocompetent people. Cryptococcosis initially affects the patient’s lungs and can spread throughout the body, such as in the brain and blood. Among them, cryptococcal meningitis is a major complication leading to patient death. In recent years, the incidence of pulmonary cryptococcosis has shown an increasing trend, while its clinical manifestations are lack of specificity and are prone to misdiagnosis and underdiagnosis. The author reviews the progress of diagnosis and treatment of pulmonary cryptococcosis, aiming to improve clinicians’ awareness and attention towards this disease, so as to increase the rate of early diagnosis and treatment of this disease and improve the prognosis of patients.

    The function and mechanism of G protein-coupled receptors in host against Mycobacterium tuberculosis infection
    Liu Haohan, Ma Zichun, Pang Yu, Li Shanshan
    Chinese Journal of Antituberculosis. 2024, 46(7):  839-844.  doi:10.19982/j.issn.1000-6621.20240118
    Abstract ( 206 )   HTML ( 12 )   PDF (774KB) ( 166 )   Save
    References | Related Articles | Metrics

    G protein-coupled receptors (GPCRs) play a critical role in maintaining normal physiological functions and intracellular homeostasis in the human body. Dysregulation of GPCRs and their downstream signaling pathways are significant markers in the development and progression of various diseases. In recent years, the prevention and treatment of tuberculosis (TB) have faced increasingly severe challenges, highlighting the urgent need for the development of new anti-TB drugs that are safe, affordable, and sensitive. Among these, novel antimicrobial drugs based on host-directed therapeutic strategies have garnered widespread attention. GPCRs, as receptors that regulate host immune expression, can serve as potential therapeutic targets for host-directed anti-TB treatment. However, researches on GPCRs as important drug targets in the field of TB are still insufficient. The author summarizes the recently discovered functions of GPCRs in host cell responses to Mycobacterium tuberculosis infection. It systematically reviews the key roles and molecular mechanisms of chemokine receptor-like GPCRs, orphan GPCRs, and other GPCRs in regulating host cell signal transduction, providing a basis for the development of GPCR-based anti-TB drugs.

Monthly, Established in Novembar 1934
ISSN 1000-6621
CN 11-2761/R

    Responsible Institution
    China Association for Science and Technology
    Sponsor
    Chinese Antituberculosis Association
    42 Dongsi Xidajie,Beijing 100710,China
    Editing
    Editorial Board of Chinese Journal of Antituberculosis
    5 Dongguang Hutong,Beijing 100035,China
    Tel(Fax): 0086-10-62257587
    http://www.zgflzz.cn
    Email: zgfIzz@163.com
    Editor-in-chief
    WANG Li-xia(王黎霞)
    Managing Director
    Ll Jing-wen(李敬文)
    Publishing
    Chinese Journal of Antituberculosis Publishing House
    5 Dongguang Hutong, Beijing 100035,China
    Tel(Fax):0086-10-62257257
    Email: zgflzz@163.com
    Printing
    Tomato Cloud Printing (Cangzhou) Co., Ltd.
    Overseas Distributor
    China International BookTrading Corporation
    P.O. Box 399,Beijing 100044,China
    Code No.M3721
Wechat